Improved leukemia-free survival after post-consolidation treatment with histamine dihydrochloride and interleukin-2 in AML: A randomized phase III trial

被引：2

作者：

Brune, M

Castaigne, S

Catalano, J

Gehlsen, K

Hofmann, WK

Ho, A

Hogge, D

Nilsson, B

Or, R

Rowe, J

Simonsson, B

Spearing, R

Stadtmauer, E

Szer, J

Wallhult, E

Hellstrand, K

机构：

[1] Univ Gothenburg, Sect Hematol, Gothenburg, Sweden

[2] Hop Versailles, Versailles, France

[3] Monash Med Ctr, Clayton, Vic, Australia

[4] Maxim Pharmaceut, San Diego, CA USA

[5] Univ Hosp, Frankfurt, Germany

[6] Univ Heidelberg, Heidelberg, Germany

[7] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

[8] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel

[9] Rambam Med Ctr, Haifa, Israel

[10] Univ Uppsala Hosp, Uppsala, Sweden

[11] Christchurch Hosp, Christchurch, New Zealand

[12] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA

[13] Royal Melbourne Hosp, Melbourne, Vic, Australia

来源：

关键词：

D O I：

10.1182/blood.V104.11.261.261

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

261

引用

页码：78A / 78A

页数：1